# Liraglutide shows promise in reducing BMI in children – Liraglutide, an FDA-approved weight loss drug for adults, shows effectiveness in reducing BMI in children aged 6 to 12. – The drug was tested on children with genetic conditions causing obesity, leading to a decrease in their BMI with regular use. – Alongside the medication, children also received lifestyle interventions to optimize weight loss results. – The study results indicate the potential for Liraglutide to be a helpful tool in combating childhood obesity. ## Positive impacts of Liraglutide on child BMI Evidence suggests that employing Liraglutide, in conjunction with behavioral changes and dietary modifications, can be beneficial in reducing BMI in children with genetic obesity. By combining this medication with healthy lifestyle habits, significant improvements in weight management can be achieved. ### A step towards better health for children Offering a potential solution for children struggling with obesity, the use of Liraglutide showcases promising results in reducing BMI and fostering healthier lifestyles. By incorporating this medication into tailored weight loss programs, children may experience positive changes that support their overall well-being. If you are interested in exploring how Liraglutide and lifestyle modifications can assist your child in achieving a healthier weight, contact Mindful Evolution for guidance. We provide telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Reach out to us at 954-639-9960 or visit our website for more information. Weight Loss Disclaimer: Individual results may vary. It is essential to consult with a healthcare professional before starting any weight loss program or medication.